Prepregnancy Cardiovascular Health, Gestational Diabetes, and Coronary Artery Calcium
- PMID: 40560557
- PMCID: PMC12199180
- DOI: 10.1001/jamacardio.2025.1887
Prepregnancy Cardiovascular Health, Gestational Diabetes, and Coronary Artery Calcium
Abstract
Importance: Poor cardiovascular health (CVH) and gestational diabetes (GD) are each associated with higher risk for cardiovascular disease (CVD). Individuals with poor CVH also have a higher risk of GD, but it remains unclear if GD mediates the association between prepregnancy CVH and CVD.
Objective: To examine whether GD is a mediator or marker of the association between prepregnancy CVH and midlife subclinical CVD.
Design, setting, and participants: This prospective, population-based cohort study was nested within the CARDIA (Coronary Artery Risk Development in Young Adults) study, which included self-identified Black and White women with up to 35 years of follow-up. This study was conducted at 4 US centers among women with at least 1 singleton birth from baseline through 15-year follow-up, available prepregnancy CVH data, available CAC data from 15- to 25-year follow-up, and no prepregnancy diabetes. Data for this study were collected from 1985 to 2010 and analyzed from 2021 to 2024.
Exposure: Prepregnancy CVH, quantified using the American Heart Association's Life's Simple 7 (score 0-14) and stratified as low or moderate (0-10) and high (11-14) based on a median split.
Main outcomes and measures: The primary outcome was CAC, quantified via computed tomography scans. Odds ratios (ORs) were calculated for GD and incident CAC greater than 0 among people with low or moderate CVH compared with high prepregnancy CVH adjusted for age, race, education, and parity. Causal mediation analyses estimated the proportion of the association between prepregnancy CVH and incident CAC mediated through GD.
Results: Of 1052 included women, mean (SD) age was 28.6 (4.5) years; 501 individuals (47.6%) self-identified as Black, and 551 individuals (52.4%) self-identified as White. Women with lower (worse) compared with high (better) prepregnancy CVH were more likely to have a pregnancy complicated by GD (8.8% vs 6.3%; adjusted OR, 1.8; 95% CI, 1.1-3.0) and were more likely to develop CAC (28.2% vs 19.2%; adjusted OR, 1.7; 95% CI, 1.2-2.5). GD mediated 6% (95% CI, 0%-22%) of the association between prepregnancy CVH and incident CAC.
Conclusions and relevance: In this cohort study, less favorable prepregnancy CVH was associated with subclinical CVD in midlife, but only a small proportion of this association was mediated through GD. This suggests that GD predominantly represents a marker of prepregnancy CVH and emphasizes the importance of improving CVH early in the life course prior to pregnancy.
Conflict of interest statement
Similar articles
-
The effectiveness and cost-effectiveness of computed tomography screening for coronary artery disease: systematic review.Health Technol Assess. 2006 Oct;10(39):iii-iv, ix-x, 1-41. doi: 10.3310/hta10390. Health Technol Assess. 2006. PMID: 17018228
-
Maternal and neonatal outcomes of elective induction of labor.Evid Rep Technol Assess (Full Rep). 2009 Mar;(176):1-257. Evid Rep Technol Assess (Full Rep). 2009. PMID: 19408970 Free PMC article.
-
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD013556. doi: 10.1002/14651858.CD013556.pub2. Cochrane Database Syst Rev. 2022. PMID: 35199850 Free PMC article.
-
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280. Health Technol Assess. 2008. PMID: 18547499
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
References
-
- Parikh NI, Gonzalez JM, Anderson CAM, et al. ; American Heart Association Council on Epidemiology and Prevention; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; and the Stroke Council . Adverse pregnancy outcomes and cardiovascular disease risk: unique opportunities for cardiovascular disease prevention in women: a scientific statement from the American Heart Association. Circulation. 2021;143(18):e902-e916. doi: 10.1161/CIR.0000000000000961 - DOI - PubMed
LinkOut - more resources
Full Text Sources
